SCOPUS 정보 검색 플랫폼

Volumn 58, Issue 1, 2014, Pages 581-583

Can levofloxacin be a useful alternative to trimethoprim-Sulfamethoxazole for treating stenotrophomonas maltophilia bacteremia?

(8) Cho, Sun Young a Kang, Cheol In a Kim, Jungok a Ha, Young Eun a Chung, Doo Ryeon a Lee, Nam Yong a Peck, Kyong Ran a Song, Jae Hoon a

a Sungkyunkwan University School of Medicine (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; COTRIMOXAZOLE; LEVOFLOXACIN; TIGECYCLINE;

ADULT; AGED; ALTERNATIVE MEDICINE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; COHORT ANALYSIS; COMPUTER SYSTEM; CYTOPENIA; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; RASH; RECURRENT INFECTION; RETROSPECTIVE STUDY; STENOTROPHOMONAS MALTOPHILIA;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LEVOFLOXACIN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84891530851 PISSN: 00664804 EISSN: 10986596 Source Type: Journal
DOI: 10.1128/AAC.01682-13 Document Type: Article

Times cited : (82)

References (14)

1
- 64849096857
- Stenotrophomonas maltophilia: An emerging opportunist human pathogen
- Looney WJ, Narita M, Muhlemann K. 2009. Stenotrophomonas maltophilia: An emerging opportunist human pathogen. Lancet Infect. Dis. 9:312-323. http://dx.doi.org/10.1016/S1473-3099(09)70083-0
- (2009) Lancet Infect. Dis , vol.9 , pp. 312-323
- Looney, W.J.¹ Narita, M.² Muhlemann, K.³

2
- 0037097654
- Attributable mortality of Stenotrophomonas maltophilia bacteremia
- Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. 2002. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin. Infect. Dis. 34:1653-1656. http://dx.doi.org/10.1086/340707
- (2002) Clin. Infect. Dis , vol.34 , pp. 1653-1656
- Senol, E.¹ DesJardin, J.² Stark, P.C.³ Barefoot, L.⁴ Snydman, D.R.⁵

3
- 84887594809
- Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients
- Demiraslan H, Sevim M, Pala C, Durmaz S, Berk V, Kaynar L, Metan G. 2013. Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients. Int. J. Hematol. 97:414-420. http://dx.doi.org/10.1007/s12185-013-1296-x
- (2013) Int. J. Hematol , vol.97 , pp. 414-420
- Demiraslan, H.¹ Sevim, M.² Pala, C.³ Durmaz, S.⁴ Berk, V.⁵ Kaynar, L.⁶ Metan, G.⁷

4
- 84879077679
- Epidemiology and clinical features of bloodstream infections in hematology wards: One year experience at the Catholic Blood and Marrow Transplantation Center
- Kwon JC, Kim SH, Choi JK, Cho SY, Park YJ, Park SH, Choi SM, Lee DG, Choi JH, Yoo JH. 2013. Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the Catholic Blood and Marrow Transplantation Center. Infect. Chemother. 45: 51-61. http://dx.doi.org/10.3947/ ic.2013.45.1.51
- (2013) Infect. Chemother , vol.45 , pp. 51-61
- Kwon, J.C.¹ Kim, S.H.² Choi, J.K.³ Cho, S.Y.⁴ Park, Y.J.⁵ Park, S.H.⁶ Choi, S.M.⁷ Lee, D.G.⁸ Choi, J.H.⁹ Yoo, J.H.¹⁰

5
- 84874775082
- Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates
- Chung HS, Hong SG, Kim YR, Shin KS, Whang DH, Ahn JY, Park YJ, Uh Y, Chang CL, Shin JH, Lee HS, Lee K, Chong Y. 2013. Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates. J. Korean Med. Sci. 28:62-66. http://dx.doi.org/10.3346/jkms.2013.28.1.62
- (2013) J. Korean Med. Sci , vol.28 , pp. 62-66
- Chung, H.S.¹ Hong, S.G.² Kim, Y.R.³ Shin, K.S.⁴ Whang, D.H.⁵ Ahn, J.Y.⁶ Park, Y.J.⁷ Uh, Y.⁸ Chang, C.L.⁹ Shin, J.H.¹⁰ Lee, H.S.¹¹ Lee, K.¹² Chong, Y.¹³

6
- 34147163353
- Antimicrobial therapy for Stenotrophomonas maltophilia infections
- Nicodemo AC, Paez JI. 2007. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur. J. Clin. Microbiol. Infect. Dis. 26:229-237. http://dx.doi.org/10.1007/s10096-007-0279-3
- (2007) Eur. J. Clin. Microbiol. Infect. Dis , vol.26 , pp. 229-237
- Nicodemo, A.C.¹ Paez, J.I.²

7
- 54549083461
- Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: A systematic review
- Falagas ME, Valkimadi PE, Huang YT, Matthaiou DK, Hsueh PR. 2008. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: A systematic review. J. Antimicrob. Chemother. 62:889- 894. http://dx.doi.org/10.1093/jac/dkn301
- (2008) J. Antimicrob. Chemother , vol.62 , pp. 889-894
- Falagas, M.E.¹ Valkimadi, P.E.² Huang, Y.T.³ Matthaiou, D.K.⁴ Hsueh, P.R.⁵

8
- 84872049998
- Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA
- Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute, Wayne, PA
- (2012) Performance standards for antimicrobial susceptibility testing

9
- 66949140382
- Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America
- Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:1-45. http://dx.doi.org/10.1086/599376
- (2009) Clin. Infect. Dis , vol.49 , pp. 1-45
- Mermel, L.A.¹ Allon, M.² Bouza, E.³ Craven, D.E.⁴ Flynn, P.⁵ O'Grady, N.P.⁶ Raad, I.I.⁷ Rijnders, B.J.⁸ Sherertz, R.J.⁹ Warren, D.K.¹⁰

10
- 0034049169
- Comparative activity of new quinolones against 326 clinical isolates of stenotrophomonas maltophilia
- Weiss K, Restieri C, De Carolis E, Laverdiere M, Guay H. 2000. Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 45:363-365. http://dx.doi.org/10.1093/jac/45.3.363
- (2000) J. Antimicrob. Chemother , vol.45 , pp. 363-365
- Weiss, K.¹ Restieri, C.² De Carolis, E.³ Laverdiere, M.⁴ Guay, H.⁵

11
- 0033971657
- Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates
- Bonfiglio G, Cascone C, Azzarelli C, Cafiso V, Marchetti F, Stefani S. 2000. Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates. J. Antimicrob. Chemother. 45:115- 117. http://dx.doi.org/10.1093/jac/45.1.115
- (2000) J. Antimicrob. Chemother , vol.45 , pp. 115-117
- Bonfiglio, G.¹ Cascone, C.² Azzarelli, C.³ Cafiso, V.⁴ Marchetti, F.⁵ Stefani, S.⁶

12
- 0037310990
- Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories
- Gesu GP, Marchetti F, Piccoli L, Cavallero A. 2003. Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories. Antimicrob. Agents Chemother. 47:816- 819. http://dx.doi.org/10.1128/AAC.47.2.816-819.2003
- (2003) Antimicrob. Agents Chemother , vol.47 , pp. 816-819
- Gesu, G.P.¹ Marchetti, F.² Piccoli, L.³ Cavallero, A.⁴

13
- 0029826627
- Stenotrophomonas maltophilia: Emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model
- Garrison MW, Anderson DE, Campbell DM, Carroll KC, Malone CL, Anderson JD, Hollis RJ, Pfaller MA. 1996. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob. Agents Chemother. 40:2859-2864
- (1996) Antimicrob. Agents Chemother , vol.40 , pp. 2859-2864
- Garrison, M.W.¹ Anderson, D.E.² Campbell, D.M.³ Carroll, K.C.⁴ Malone, C.L.⁵ Anderson, J.D.⁶ Hollis, R.J.⁷ Pfaller, M.A.⁸

14
- 1442275661
- Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokineticpharmacodynamic model
- Ba BB, Feghali H, Arpin C, Saux MC, Quentin C. 2004. Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokineticpharmacodynamic model. Antimicrob. Agents Chemother. 48:946-953. http://dx.doi.org/10.1128/AAC. 48.3.946-953.2004
- (2004) Antimicrob. Agents Chemother , vol.48 , pp. 946-953
- Ba, B.B.¹ Feghali, H.² Arpin, C.³ Saux, M.C.⁴ Quentin, C.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.